Aberrant activation of Th2 is an important trigger for the pathogenesis of AD, and mTOR has been shown to regulate Th2 activation by AKT, which makes the PI3K/AKT/mTOR pathway an effective strategy for AD [43]. Here, AKT1 is linked to Alzheimer disease.